WASHINGTON — The U.S. Food and Drug Administration is expected to authorize Pfizer’s COVID-19 vaccine for youngsters ages 12 to 15 by next week, according to a federal official and a person familiar with the process, setting up shots for many before the beginning of the next school year. The announcement is set to come… Read More: FDA expected to OK Pfizer vaccine for teenagers within week »
“Those who are vaccine hesitant have had their hesitancy enhanced by a variety of things that are happening right now, particularly the unfortunate mix of science and politics,” Collins said at an event hosted by the National Academies of Sciences, Engineering and Medicine. A recent poll from the Kaiser Family Foundation found that more than… Read More: Most Americans probably won’t be able to get a Covid-19… »
National Institute of Allergy and Infectious Diseases Director Dr. Anthony Fauci talks to reporters in the Brady Press Briefing Room at the White House on April 13, 2021 in Washington, DC. Chip Somodevilla | Getty Images People who get infected with the coronavirus between Covid-19 vaccine shots can get their second dose after they’ve recovered… Read More: Fauci says people who get Covid between vaccine shots can… »
The global COVID-19 vaccine supply is about to take another hit, but this time from Moderna. The mRNA drugmaker warned Friday that supply problems are forcing it to cut back deliveries to “a number of countries,” including the U.K. and Canada. Moderna, which has partnered with Switzerland’s Lonza to manufacture its vaccine known as mRNA-1273, pinned the reduction on deficits in… Read More: Moderna cuts COVID-19 vaccine deliveries to Canada, U.K. amid European… »